Avinger Inc AVGR.OQ reported a quarterly adjusted loss of $1.82 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-2.92. The lone analyst forecast for the quarter was for a loss of $2.03 per share.
Revenue fell 9.2% to $1.65 million from a year ago; analysts expected $1.64 million.
Avinger Inc's reported EPS for the quarter was a loss of $1.82.
The company reported a quarterly loss of $4.06 million.
Avinger Inc shares had fallen by 14.6% this quarter and lost 70.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Avinger Inc is $5.00
This summary was machine generated from LSEG data November 8 at 09:03 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -2.03 | -1.82 | Beat |
Jun. 30 2024 | -0.43 | -2.82 | Missed |
Mar. 31 2024 | -1.35 | -2.49 | Missed |
-3.93 |
Comments